JPRN-UMIN000021375招募中未知
Single agent graft-versus-host disease prophylaxis with post-transplant cyclophosphamide for stem cell transplantation: a phase II study (SAP-P2) - Single agent GVHD prophylaxis with PTCY for SCT: a phase II study (SAP-P2)
ational Center for Child Health and Development0 个研究点目标入组 30 人开始时间: 2016年3月7日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- ot applicable 至 20years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1. Prior allogeneic stem cell transplantation 2. Effusion with grade 2 or worse at CTCAE ver 4.0 3. Uncontrolled infection 4. Severe psychological disorders 5. Pregnant or suspected pregnancy 6. Not eligible for this study at the discretion of the investigator.
研究者
相似试验
招募中
2 期
Single agent GVHD prophylaxis with PTCY for SCT: a phase II studyeukemia/lymphomaHematologic malignancyJPRN-jRCTs031180399Sakaguchi Hirotoshi30
进行中（未招募）
1 期
Prevention of graft-against-host disease in patients treated with allogeneic stem cell transplantation: Possible role of extracorporeal photophoresisGraft-versus-host disease (GVHD), both acute and chronic untill one year after allogeneic stam cell transplatationEUCTR2017-000614-39-NOOSLO UNIVERSITY HOSPITAL HF156
招募中
3 期
Graft versus host disease prevention/reduction by microbiome and patient blood management in allogeneic hematopoietic stem cell transplant patientsGraft-versus-host diseaseCondition 1: graft versus host disease. Condition 2: acute graft versus host disease.Acute graft-versus-host diseaseD89.81D89.810IRCT20190914044766N1High Institute for Research and Education in Transfusion Medicine40
进行中（未招募）
3 期
GRAPPA2023-510441-24-00DKMS Group gGmbH640
进行中（未招募）
1 期
Prophylaxis of chronic graft-versus-host disease (cGvHD) with or without anti-thymocyte-globulin (ATG) prior allogeneic peripheral stem cell transplantation from HLA-identical siblings after myeloablative conditioning in patients with acute leukemia: a randomized phase III-study - NDAcute myeloid leukemia in first or subsequent complete remissionMedDRA version: 9.1Level: HLTClassification code 10024291Term: Leukaemias acute myeloidEUCTR2005-005719-83-ITAZIENDA OSPEDALIERA DI BOLOGNA POLICLINICO S. ORSOLA M. MALPIGHI160